Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1995-4-20
|
pubmed:abstractText |
To date, it has remained unclear whether orbit-infiltrating T cells in patients with Graves' ophthalmopathy (GO) represent a primary immune response in which a limited number of T cell clones driving the disease are activated against specific antigens, or whether they participate in a non-specific inflammatory process. To characterize these T cells at the molecular level, we examined the T cell antigen receptor (TcR) V gene repertoire in situ in retroorbital tissue specimens obtained from patients with early and late stages of clinically severe GO and from patients with non-GO orbital conditions. Ribonucleic acid extracted from orbital tissue and peripheral blood lymphocytes (PBL) was reverse transcribed and amplified using the polymerase chain reaction and 22 V alpha and 24 V beta gene-specific oligonucleotide primers. The resulting TcR V alpha and V beta transcripts were verified by Southern hybridization analysis using TcR C region-specific, digoxigenin-labeled oligonucleotide probes. Compared with matched PBL, the retroorbital TcR V alpha and V beta gene repertoire expressed was heterogeneous, but revealed marked restriction of V gene usage in samples derived from retroorbital connective tissue and extraocular muscle of all eight patients with severe GO of short duration studied. In contrast, greater diversity of the TcR V beta gene repertoire and loss of TcR V alpha gene restriction was noted in four patients with late GO undergoing reconstructive eye muscle surgery. Unrestricted TcR V gene usage was demonstrated in orbital tissue and PBL samples obtained from control subjects. These results suggest that retroorbital TcR V gene usage is variable but markedly restricted during the earlier stages of GO. With increasing disease duration, greater diversity of the TcR V gene repertoire appears to develop, and oligoclonality of the T cell response may be lost. Selection of patients with early stages of GO will be important when further dissecting TcR usage and antigen specificity of orbit-infiltrating T lymphocytes in GO.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0804-4643
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
132
|
pubmed:geneSymbol |
V&agr;,
V&bgr;
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
266-77
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7889172-Adult,
pubmed-meshheading:7889172-Base Sequence,
pubmed-meshheading:7889172-Blotting, Southern,
pubmed-meshheading:7889172-Down-Regulation,
pubmed-meshheading:7889172-Female,
pubmed-meshheading:7889172-Graves Disease,
pubmed-meshheading:7889172-Humans,
pubmed-meshheading:7889172-Immunoenzyme Techniques,
pubmed-meshheading:7889172-Male,
pubmed-meshheading:7889172-Middle Aged,
pubmed-meshheading:7889172-Molecular Sequence Data,
pubmed-meshheading:7889172-Orbit,
pubmed-meshheading:7889172-Phenotype,
pubmed-meshheading:7889172-Polymerase Chain Reaction,
pubmed-meshheading:7889172-Receptors, Antigen, T-Cell,
pubmed-meshheading:7889172-T-Lymphocytes
|
pubmed:year |
1995
|
pubmed:articleTitle |
Analysis of retroorbital T cell antigen receptor variable region gene usage in patients with Graves' ophthalmopathy.
|
pubmed:affiliation |
Molecular Thyroid Research Unit, Klinikum Innenstadt, Ludwig-Maximilians-Universität, München, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|